نتایج جستجو برای: pioglitazone

تعداد نتایج: 2877  

Journal: :iranian journal of basic medical sciences 0
said said elshama department of forensic medicine and clinical toxicology, college of medicine, taif university, suez canal university, taif, ksa ayman el-meghawry el-kenawy department of pathology, college of medicine, taif university, taif, ksa department of molecular biology, gebri, university of sadat city, egypt hosam-eldin hussein osman department of anatomy, college of medicine, taif university, al-azhar university, taif, ksa

objective(s): pioglitazone (actos) is one of the most controversial recent oral antidiabetic drugs. it was originally authorized in the european :union: in 2000, and approved as an oral monotherapy for overweight second type of diabetic patients in 2002. it belongs to the thiazolidinedione group which some of its members have been withdrawn from the market due to the hepatotoxicity or cardiotox...

Objective(s): Testicular torsion/detorsion (T/D) is a well-known cause for infertility. Pioglitazone is an agonist of peroxisome proliferator activated receptor-gamma (PPAR-γ). Previous studies have shown that pioglitazone has anti-inflammatory, antioxidant and antiapoptotic properties. The present study hypothesized that pioglitazone may be protective against the test...

Behnaz Danesh Gholam Abbas Mohammadi Hosein Fallah, Samaneh Rahemi

Backgrounds: Insulin resistance is a pathological condition associated with metabolic syndrome. In this condition, insulin action in liver, muscles, and adipocytes decreases which leads to hyperglycemia, hyperinsulinemia, and dyslipidemia. Thiazolidinediones (Pioglitazone) have been used to enhance insulin sensitivity but due to dyslipidemia associated with insulin resistance, ...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه اصفهان - دانشکده علوم 1392

سلول های بنیادی جنینی انسانی قابلیت های شگرفی در حوزه ی پزشکی و سلول درمانی دارند. در این راستا، منفرد کردن سلول های بنیادی انسانی با هدف گسترش سریع این سلول ها و انجام دست ورزی های مختلف بر روی آن ها اجتناب ناپذیر است. اما در این فرایند مانعی وجود دارد، بدین معنا که آپوپتوز القا شده در اثر فعالیت مسیر سیگنالی rho/rock که در نتیجه ی منفرد شدن سلول های بنیادی انسانی فعال می شود، کشت و دست ورزی ا...

Fatemeh Ghaedamini, Ghazal Gholampour, Zeinab Ghodsi pour,

More than 10 million people worldwide are living with Parkinson’s disease (PD). The ages of people who have Parkinson are variable, usually between 50 and 80 years, the average of them is 55 years old. The symptoms of PD are progressive, and within 10 to 20. It happens when dopaminergic neurons were being degenerate. Peripheral and central inflammatory and oxidative stress pathways play a...

A. Zare Shahneh A.R. Yousefi F. Ghaziani H. Kohram, H.A. Arab M. Kazemi Khoozani M.J. Zamiri S.M. Ghoreishi

Pioglitazone belongs to the thiazolidinedione (TZD) class of antidiabetic agents, with proven efficacy in increasing insulin sensitivity and in the treatment of type 2 diabetes mellitus in humans. Pioglitazone has been proposed as a potential feed additive to reduce insulin resistance and consequently some of the metabolic disorders in transition cows. This study was aimed at determining the ph...

2015
Kai Lun Chang Hai Ning Pee Shili Yang Paul C. Ho

Pioglitazone is currently undergoing clinical trials for treatment of Alzheimer's disease (AD). However, poor brain penetration remains an obstacle to development of the drug for such intended clinical uses. In this study, we demonstrate that the inhibition of P-glycoprotein (P-gp) significantly increases brain penetration of pioglitazone, whereas inhibition of breast cancer resistance protein ...

Insulin resistance is a feature of most patients with type 2 diabetes mellitus. Epidemiological evidence suggests a correlation between inflammation and insulin resistant states such as obesity, but the underlying mechanisms are largely unknown. Interleukin-1 receptor-associated kinases (IRAK) play a central role in inflammatory responses by regulating the expression of various inflammatory gen...

Fatemeh Aghaei Meybodi, Miaad Hassani Kaboutarkhani, Nasim Namiranian, Reyhaneh Azizi, Saeedeh Jam Ashkezari, Somaye Gholami, Zahra Davoudi,

Objective: Pioglitazone is one of the oral medications of type 2 diabetes (T2DM). The purpose of this study was to evaluate the effect of pioglitazone on asthma and diabetes treatment outcomes among patients with concurrent asthma and T2DM. Materials and Methods: We conducted a quasi-experimental study on 11 patients with concurrent asthma and T2DM in Yazd Afshar Hospital and Yazd diabetic res...

2017
Hidekatsu Yanai Hiroki Adachi

Pioglitazone is one of thiazolidinedione derivatives, which stimulates nuclear peroxisome proliferator-activated receptor gamma and improves glucose and lipid metabolism and insulin sensitivity. A recent systematic review and meta-analysis showed that pioglitazone therapy was associated with a lower risk of major adverse cardiovascular events in patients with pre-diabetes and diabetes. Further,...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید